Ambipar (AMBP3), which is in judicial recovery, postponed the release of its quarterly financial information (ITR) for the third quarter of 2026 (3Q26), which had been scheduled for November 16, 2026. According to the company, the delay stems mainly from the judicial recovery process, which affected the completion of the work to compile and prepare the financial and accounting information.

The company said it is making every effort to release, as soon as possible, the 3Q25 ITR, the 2025 financial statements, the 1Q26 and 2Q26 ITRs, and the 3Q26 ITR. In other words, in addition to 3Q26, earlier financial reports remain pending publication.

Ambipar's judicial recovery was detailed in Material Facts released on September 25, October 20 and October 30, 2025. The company said it will keep shareholders informed on the matter.

Source: Notice to the Market, filed with the CVM on 11/16/2026 21:50. View original document

For information only; not investment advice.

Is AMBP3 worth investing in?

AMBP3Ambipar · B3
Price
R$ 0.13
as of 11/13/2026
Dividend yield
0.00 %
P/L
N/A
P/VPA
0.20
View full analysis of AMBP3